PRELUDE CAPITAL MANAGEMENT, LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 153 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$95,685
+1813.7%
10,973
+631.5%
0.01%
Q2 2020$5,0000.0%1,500
+95.6%
0.00%
Q2 2019$5,000
-37.5%
767
-23.7%
0.00%
Q4 2018$8,000
-11.1%
1,005
+24.1%
0.00%
-100.0%
Q3 2018$9,000
-25.0%
810
-10.6%
0.00%0.0%
Q1 2018$12,000
+140.0%
906
+84.9%
0.00%
Q4 2017$5,000
-91.2%
490
-93.1%
0.00%
-100.0%
Q3 2017$57,0007,1000.01%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders